Senate Bill Would Require Clinical Trials To Test Gender, Racial Differences In Therapies
In Brief: Alfred Ketcham Is New SSO President; Meyskens Receives NCI Year 2000 Award; Colman Honored
Banned Investigator Plans To Resume Clinical Trials Role
Gene Therapy Experiments Get RDAC Okay
Tobacco Control Bill Requires Stronger Warnings
No Cancer Letter For Two Weeks
Trending Stories
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









